Ga-68 FAPI PET Before Immunotherapy
Prognostic Significance of Ga-68 FAPI PET Before Immunotherapy in Pleural Mesothelioma
Ankara University
30 participants
Apr 30, 2024
INTERVENTIONAL
Conditions
Summary
It is aimed to evaluate FAP expression and its success in predicting treatment response before immunotherapy used in the treatment of malignant mesothelioma with Ga68 FAPI PET/CT imaging, which allows in vivo evaluation of FAP expression, which is thought to be associated with immunosuppression and resistance to immunotherapy.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
imaging of FAP expression of tumor before immunotherapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06451536